Cogstate Limited Stock Today
| COGZF Stock | USD 0.69 0.01 1.43% |
Performance4 of 100
| Odds Of DistressLess than 10
|
Cogstate is trading at 0.69 as of the 31st of January 2025. This is a 1.43 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.69. Cogstate has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia. Cogstate operates under Health Information Services classification in the United States and is traded on OTC Exchange. The company has 173.46 M outstanding shares. More on Cogstate Limited
Moving against Cogstate OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cogstate OTC Stock Highlights
| Business Concentration | Health Information Services, Healthcare (View all Sectors) |
Cogstate Limited [COGZF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with a current market capitalization of 264.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cogstate's market, we take the total number of its shares issued and multiply it by Cogstate's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cogstate Limited classifies itself under Healthcare sector and is part of Health Information Services industry. The entity has 173.46 M outstanding shares.
Cogstate Limited has accumulated about 30.6 M in cash with 9.73 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Check Cogstate Probability Of Bankruptcy
Ownership AllocationCogstate holds a total of 173.46 Million outstanding shares. Cogstate Limited retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cogstate Ownership Details
Cogstate Limited Risk Profiles
| Mean Deviation | 1.45 | |||
| Semi Deviation | 2.22 | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.62 |
Cogstate Stock Against Markets
Picking the right benchmark for Cogstate otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cogstate otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cogstate is critical whether you are bullish or bearish towards Cogstate Limited at a given time. Please also check how Cogstate's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cogstate without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Cogstate Corporate Management
Elected by the shareholders, the Cogstate's board of directors comprises two types of representatives: Cogstate inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cogstate. The board's role is to monitor Cogstate's management team and ensure that shareholders' interests are well served. Cogstate's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cogstate's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BBus CA | MD CEO | Profile | |
| Kenneth Billard | Chief Officer | Profile | |
| Pr BBSc | Founder Officer | Profile | |
| Darren Watson | Chief Officer | Profile | |
| Rachel Colite | Communication Initiatives | Profile | |
| Chris Edgar | Chief Officer | Profile | |
| Benjamin Bloomfield | Chief Officer | Profile |
Other Information on Investing in Cogstate OTC Stock
Cogstate financial ratios help investors to determine whether Cogstate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cogstate with respect to the benefits of owning Cogstate security.